Roche Announces Changes to Board of Directors - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Roche Announces Changes to Board of Directors



Roche has proposed that the following members of its board of directors be re-elected at the company’s annual general meeting, scheduled for March 4, 2014.

André Hoffmann, member since 1996; Dr. Andreas Oeri, member since 1996; Prof. Dr. Pius Baschera, member since 2007; Prof. Sir John Irving Bell, member since 2001; Paul Bulcke, member since 2011; Dr. Christoph Franz, member since 2011; Dame DeAnne Julius, member since 2002; Dr. Arthur D. Levinson, member since  2010; Dr. Severin Schwan, member since 2013; Peter R. Voser, member since 2011; Prof. Dr. Beatrice Weder di Mauro, member since 2006.

As announced on Sept. 16, 2013, the board proposes Christoph Franz to be elected as chairman of the board.

William M. Burns, member of the board of directors since 2010, has announced that he will not stand for re-election to the board of directors.

Source: Roche

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here